reports
- GlobalData Healthcare Department
Gabather AB - Company Review
Gabather AB - Company Review Summary Gabather AB (Gabather) focuses on the development of new drug candidates for the treatment of central nervous system diseases. The company spans its expertise in the development of antipsychotics, antidepressants and anti-anxiety drugs, memory and cognition-enhancing drugs and pain-treating drugs. Gabather’s main assets include two patent families, Quinazolinderivat and Triazoloderivat, which contain drug candidates in form of small molecules that integra...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.